Page 6 - கேடோஸ் அடிப்படையிலானது அர்ஸ் ப்யாக்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேடோஸ் அடிப்படையிலானது அர்ஸ் ப்யாக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேடோஸ் அடிப்படையிலானது அர்ஸ் ப்யாக்ஸ் Today - Breaking & Trending Today

5 Top Weekly TSX Stocks: Western Copper Up After Rio's Investment


Here’s a look at those companies and the factors that moved their share prices last week.
1. Globex Mining Enterprises
Globex Mining Enterprises has a diversified North American portfolio of mid-stage exploration, development and royalty properties containing precious metals, base metals, specialty metals and minerals and industrial minerals and compounds.
Despite not releasing news last week, Globex saw its share price rise 36.19 percent to C$1.43.
2. Gatos Silver
Gatos Silver is a silver-dominant exploration, development and production company that discovered a new silver- and zinc-rich mineral district in Mexico’s Chihuahua state. To date, 14 zones of mineralization have been defined in the district and all are characterized by silver-zinc-lead epithermal mineralization. ....

United States , Queréro De Arteaga , Dublin Gulch , Priscila Barrera , Globex Mining Enterprises , Globex Mining , Gatos Silver , Victoria Gold , Western Copper , Wesdome Gold , Caused This Sharp , More Importantly , Can You Afford To Miss , Mining Enterprises , North American , Canadian Creek , Newmont Goldcorp , Rio Tinto Canada , Gold Mines , Kiena Deep , Wesdome Gold Mines , ஒன்றுபட்டது மாநிலங்களில் , டப்ளின் குல்ச் , பிரிஸ்ஸில பாரேரா , குளோபெக்ஸ் சுரங்க நிறுவனங்கள் , குளோபெக்ஸ் சுரங்க ,

Aridis Pharmaceuticals Announces First Quarter 2021 Results


Aridis Pharmaceuticals Announces First Quarter 2021 Results
News provided by
Share this article
Share this article
LOS GATOS, Calif., May 11, 2021 /PRNewswire/  Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today reported financial and corporate results for the first quarter ended March 31, 2021. 
First Quarter Highlights
Announced the addition of a second inhaled monoclonal antibody ( mAb ) to neutralize newly emerging COVID-19 mutated variant to form a cocktail of two mAbs. The expansion of COVID virus strain coverage, combined with the product s self-administered, at-home treatment modality, further differentiates the company s AR-712 COVID treatment offering. A clinical Phase 1/2 study is expected to be launched in 2H 2021. ....

South Africa , Los Gatos , United States , Vu Truong , Broad Institute , Aridis Pharmaceuticals , Aridis Pharmaceuticals Inc , Cf Foundation , Exchange Commission , Development Expenses , Coronavirus Immunotherapy Consortium Co , Kermode Biotechnologies Inc , European Medicines Agency , Serum Institute Of India , Clinical Program , Redchip Companies , Kermode Biotechnologies , Chief Executive Officer , Orphan Drug Designation , Fast Track , Qualified Infectious Disease Product , Quarter Results , Administrative Expenses , Equity Method Investment , Serum Institute , லாஸ் கேடோஸ் ,